Found 10 matching trials
the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer PHASE2 This study is a multicenter, single-arm, open-label Phase II exploratory cl...
Show More Location
Breast surgery department
Learn More & Join Trial
A Deep Learning Method to Evaluate QT on Ribociclib N/A "Deep-learning" is a fast-growing method of machine learning (artificial in...
Show More Location
Groupe Ambroise Paré, Hartmann
Learn More & Join Trial
Ribociclib for HR-positive HER2-negative Metastatic Breast Cancer PHASE1 This document outlines an investigator-initiated Phase Ib/II clinical trial...
Show More Location
Nagoya City University
Learn More & Join Trial
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics PHASE1 This is an open-label, multi-center, phase I study designed to assess the m...
Show More Location
Huntsman Cancer Institute
Learn More & Join Trial
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer PHASE1 This is an open-label, FIH study designed to evaluate the maximum tolerated...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer N/A The goal of this observational study is to learn about the effects of using...
Show More Location
Second Affiliated Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy PHASE2 This is a Phase II, two-arm, single center, patient preference study design...
Show More Learn More & Join Trial
Ribociclib and Bicalutamide in AR+ TNBC PHASE1 This is an open label, multi-institutional, single arm phase II trial of ri...
Show More Status
Active Not Recruiting
Location
University of Illinois Cancer Center
Learn More & Join Trial
Ribociclib and Spartalizumab in R/M HNSCC PHASE1 This study examines the safety and efficacy of ribociclib (CDK 4/6 inhibito...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer PHASE2 This is an open label, multicenter, single arm phase II study to evaluate t...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial